22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › PACIRA BIOSCIENCES INC. › 2024-2025

PACIRA BIOSCIENCES INC. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and PACIRA BIOSCIENCES INC.’s Form 8-K, filed June 13, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 7Reported items
  • 291Asset managers, any item
  • 2,664Fund votes
  • June 10, 2025Meeting date

Results at a glance

Meeting of June 10, 2025: 6 items on PACIRA BIOSCIENCES INC.’s Form 8-K, filed June 13, 2025: 5 passed (calculated) · 1 failed (calculated).

Dissent

Significant dissent: 1 director (23.1% against); 1 say-on-pay vote (39.5% support); 1 equity or compensation plan (41.0% against).

Notable dissent: 2 directors (12.1%, 10.7% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Activist investors: Doma Perpetual Capital Management LLC (as of June 9, 2026)

Explore PACIRA BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by PACIRA BIOSCIENCES INC.

These tallies are PACIRA BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

PACIRA BIOSCIENCES INC. — official shareholder meeting results, meeting held June 10, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Marcelo Bigal 33,364,221---- 4,017,5878,909,022 89%Passed (calculated)—
Elect Director: Frank D. Lee 32,858,858---- 4,522,9508,909,022 88%Passed (calculated)—
Elect Director: Alethia Young 28,757,450---- 8,624,3588,909,022 77%Passed (calculated)—
2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 40,022,569352,94720,917 ---- 99.1%Passed (calculated)—
3. Advisory vote to approve the compensation of the Company's named executive officers 14,752,82922,595,20233,777 --8,909,022 40%Failed (calculated)—
5. Approval of the Company's Amended and Restated 2011 Stock Incentive Plan 22,043,90215,317,58820,318 --8,909,022 59%Passed (calculated)—

Source: PACIRA BIOSCIENCES INC., Form 8-K, filed with the SEC on June 13, 2025 — read the filing on EDGAR.

How asset managers voted at the PACIRA BIOSCIENCES INC. 2024-2025 meeting

291 asset managers disclosed a vote on at least one PACIRA BIOSCIENCES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PACIRA BIOSCIENCES INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

Elect Director: Alethia Young

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

77% Majority: yes · of votes cast

FOR 77%WITHHELD
FOR: 28,757,450WITHHELD: 8,624,358
Details: description as filed, official tally, votes by 90 asset managers

Description as filed by funds: Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified: Alethia Young

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Alethia Young”): 28,757,450 for, 8,624,358 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 77% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 90 asset managers below reported 16,876,755 for, 2,110,850 withheld, 2,449 abstained.

FOR
FOR: 16,876,755ABSTAIN: 2,449WITHHOLD: 2,110,850
Largest asset managers voting on “Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stock” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,389,4230 172,256For
BlackRock4,964,8570 0233,675For
Fidelity1,133,5260 020,577For
American Century685,6990 00For
Pacer Funds Trust536,6160 00For
State Street2,0660 0522,386Withhold
IMPAX FUNDS SERIES TRUST I520,0270 00For
TIAA511,9810 00For
Charles Schwab00 0470,353Withhold
Dimensional00 0462,129Withhold
Columbia Threadneedle359,7980 00For
Invesco348,5440 00For
DWS257,1310 00For
EA Series Trust229,0570 00For
JPMorgan201,6120 00For
Nationwide128,8650 00For
SEI00 0128,110Withhold
Equitable73,6260 051,500Mixed
Victory Capital115,7450 00For
Jackson National79,7220 011,963Mixed
Northern Trust88,2500 00For
GuideStone79,5870 00For
QUANTITATIVE MASTER SERIES LLC78,4750 00For
AIG/SunAmerica76,4050 00For
Hartford74,8610 00For

Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).

Elect Director: Frank D. Lee

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%
FOR: 32,858,858WITHHELD: 4,522,950
Details: description as filed, official tally, votes by 90 asset managers

Description as filed by funds: Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified: Frank D. Lee

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Frank D. Lee”): 32,858,858 for, 4,522,950 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 90 asset managers below reported 18,483,844 for, 503,768 withheld, 2,442 abstained.

FOR
FOR: 18,483,844ABSTAIN: 2,442WITHHOLD: 503,768
Largest asset managers voting on “Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stock” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,391,6860 100For
BlackRock5,198,5320 00For
Fidelity1,154,1030 00For
American Century685,6990 00For
Pacer Funds Trust536,6160 00For
State Street524,4520 00For
IMPAX FUNDS SERIES TRUST I520,0270 00For
TIAA511,9810 00For
Charles Schwab470,3530 00For
Dimensional00 0462,129Withhold
Columbia Threadneedle359,7980 00For
Invesco348,5440 00For
DWS257,1310 00For
EA Series Trust229,0570 00For
JPMorgan201,6120 00For
Nationwide128,8650 00For
SEI128,1100 00For
Equitable125,1260 00For
Victory Capital115,7450 00For
Jackson National79,7220 011,963Mixed
Northern Trust88,2500 00For
GuideStone79,5870 00For
QUANTITATIVE MASTER SERIES LLC78,4750 00For
AIG/SunAmerica76,4050 00For
Hartford74,8610 00For

Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).

Elect Director: Marcelo Bigal

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

89% Majority: yes · of votes cast

FOR 89%
FOR: 33,364,221WITHHELD: 4,017,587
Details: description as filed, official tally, votes by 90 asset managers

Description as filed by funds: Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified: Marcelo Bigal

PACIRA BIOSCIENCES INC.’s own tally for this item (“Elect Director: Marcelo Bigal”): 33,364,221 for, 4,017,587 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 89% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 90 asset managers below reported 17,879,433 for, 1,108,184 withheld, 2,438 abstained.

FOR
FOR: 17,879,433ABSTAIN: 2,438WITHHOLD: 1,108,184
Largest asset managers voting on “Election of three Class II directors to our Board of Directors to serve until the 2028 annual meeting of stock” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,391,6900 60For
BlackRock5,198,5320 00For
Fidelity1,154,1030 00For
American Century685,6990 00For
Pacer Funds Trust536,6160 00For
State Street2,0660 0522,386Withhold
IMPAX FUNDS SERIES TRUST I520,0270 00For
TIAA511,9810 00For
Charles Schwab470,3530 00For
Dimensional00 0462,129Withhold
Columbia Threadneedle359,7980 00For
Invesco348,5440 00For
DWS257,1310 00For
EA Series Trust229,0570 00For
JPMorgan201,6120 00For
Nationwide128,8650 00For
SEI128,1100 00For
Equitable73,6260 051,500Mixed
Victory Capital115,7450 00For
Jackson National79,7220 011,963Mixed
Northern Trust88,2500 00For
GuideStone79,5870 00For
QUANTITATIVE MASTER SERIES LLC78,4750 00For
AIG/SunAmerica76,4050 00For
Hartford74,8610 00For

Showing the 25 largest of 90 asset managers. All 90 are in the interactive database (link above).

Approval of the Company's Amended and Restated 2011 Stock Incentive Plan

Calculated outcomeCOMPENSATIONPassed (calculated)

Combines 4 wordings of this item as funds reported it.

59% Majority: yes · of votes cast

FOR 59%AGAINST
FOR: 22,043,902AGAINST: 15,317,588
Details: description as filed, official tally, votes by 95 asset managers

Description as filed by funds: APPROVAL OF OUR AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN.

PACIRA BIOSCIENCES INC.’s own tally for this item (“5. Approval of the Company's Amended and Restated 2011 Stock Incentive Plan”): 22,043,902 for, 15,317,588 against, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 59% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 95 asset managers below reported 15,111,634 for, 4,046,572 against, 10,119 abstained.

FORAGAINST
FOR: 15,111,634AGAINST: 4,046,572ABSTAIN: 10,119
Largest asset managers voting on “APPROVAL OF OUR AMENDED AND RESTATED 2011 STOCK INCENTIVE PLAN.” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,375,66416,032 00For
BlackRock5,198,5320 00For
Fidelity1,146,7587,345 00For
American Century0685,699 00Against
Pacer Funds Trust0536,616 00Against
State Street523,770682 00For
IMPAX FUNDS SERIES TRUST I520,0270 00For
TIAA511,9810 00For
Charles Schwab470,3530 00For
Dimensional0462,129 00Against
Columbia Threadneedle0359,798 00Against
Invesco0348,544 00Against
DWS0257,131 00Against
EA Series Trust229,0570 00For
JPMorgan201,6120 00For
Simplify Exchange Traded Funds133,3470 00For
Nationwide1,322127,543 00Against
SEI128,1100 00For
Equitable73,62651,500 00Mixed
Victory Capital0115,745 00Against
Jackson National091,685 00Against
Northern Trust088,250 00Against
GuideStone079,587 00Against
QUANTITATIVE MASTER SERIES LLC78,4750 00For
AIG/SunAmerica076,405 00Against

Showing the 25 largest of 95 asset managers. All 95 are in the interactive database (link above).

Advisory vote to approve the compensation of the Company's named executive officers

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESFailed (calculated)

Combines 7 wordings of this item as funds reported it.

40% Majority: no · of votes cast

FOR 40%AGAINST
FOR: 14,752,829AGAINST: 22,595,202
Details: description as filed, official tally, votes by 290 asset managers

Description as filed by funds: Approval, on an advisory basis, of the compensation of our named executive officers.

PACIRA BIOSCIENCES INC.’s own tally for this item (“3. Advisory vote to approve the compensation of the Company's named executive officers”): 14,752,829 for, 22,595,202 against, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Failed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for did not exceed votes against.
Support: 40% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 92 asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers.” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,369,47422,222 00For
BlackRock233,6754,964,857 00Against
Fidelity1,126,65527,448 00For
American Century0685,699 00Against
Pacer Funds Trust536,6160 00For
State Street523,1481,304 00For
IMPAX FUNDS SERIES TRUST I520,0270 00For
TIAA0511,981 00Against
Charles Schwab0470,353 00Against
Dimensional0462,129 00Against
Columbia Threadneedle0359,798 00Against
Invesco0348,544 00Against
DWS0257,131 00Against
EA Series Trust0229,057 00Against
JPMorgan201,6120 00For
Simplify Exchange Traded Funds133,3470 00For
Nationwide1,320127,545 00Against
SEI128,1100 00For
Equitable0125,126 00Against
Victory Capital0115,745 00Against
Jackson National79,72211,963 00Mixed
Northern Trust088,250 00Against
GuideStone079,587 00Against
QUANTITATIVE MASTER SERIES LLC078,475 00Against
AIG/SunAmerica076,405 00Against

Fund voting reports, all 92 managers: 9,411,777 for, 9,746,405 against, 10,119 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 221 asset managers voting on “Approval, on an advisory basis, of the compensation of our named executive officers.” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock408,5201,568,080 00Mixed
State Street1,334,03323,251 00For
Alyeska Investment Group, L.P.01,285,660 00Against
Renaissance01,177,924 00Against
GEODE CAPITAL MANAGEMENT, LLC1,148,7760 00For
American Century0735,215 00Against
Invesco0535,721 00Against
Charles Schwab0529,644 00Against
IMPAX ASSET MANAGEMENT LLC520,0270 00For
Nuveen0518,482 00Against
BALYASNY ASSET MANAGEMENT L.P.509,9720 00For
J. Goldman & Co LP473,8130 00For
DE Shaw0435,843 00Against
Wellington421,1220 00For
JACOBS LEVY EQUITY MANAGEMENT, INC0370,521 00Against
Northern Trust0337,181 00Against
PARAMETRIC PORTFOLIO ASSOCIATES LLC0331,854 00Against
JPMorgan293,9550 00For
Goldman Sachs272,3350 00For
PRINCIPAL GLOBAL INVESTORS0268,416 00Against
MELLON INVESTMENTS Corp197,3920 00For
SEI186,3368,037 00For
RICE HALL JAMES & ASSOCIATES, LLC191,9030 00For
Dimensional0178,399 00Against
Vanguard167,3522,829 00For

Institutional-manager reports, all 221 managers: 7,015,053 for, 10,521,461 against, 5,765 abstained, 58,939 1 year. Showing the 25 largest; every one is in the interactive database (link above).

Advisory vote to approve the frequency of future advisory votes to approve the compensation of our named executive…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

29% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 279 asset managers

Description as filed by funds: Advisory vote to approve the frequency of future advisory votes to approve the compensation of our named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 88 asset managers voting on “Advisory vote to approve the frequency of future advisory votes to approve the compensation of our named execu” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard00 00--
BlackRock00 00--
Fidelity00 00--
American Century00 00--
Pacer Funds Trust00 00--
State Street00 00--
IMPAX FUNDS SERIES TRUST I00 00--
TIAA00 00--
Charles Schwab00 00--
Dimensional00 00--
Columbia Threadneedle00 00--
Invesco00 00--
DWS00 00--
EA Series Trust00 00--
JPMorgan00 00--
Nationwide00 00--
SEI00 00--
Equitable00 00--
Victory Capital00 00--
Jackson National00 00--
Northern Trust00 00--
QUANTITATIVE MASTER SERIES LLC00 00--
AIG/SunAmerica00 00--
Hartford00 00--
Lincoln Financial23,5010 00For

Fund voting reports, all 88 managers: 23,501 for, 4,354 abstained, 18,352,783 1 year, 493,918 3 year, 0 2 year. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 215 asset managers voting on “Advisory vote to approve the frequency of future advisory votes to approve the compensation of our named execu” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock00 00--
State Street00 00--
Alyeska Investment Group, L.P.00 00--
Renaissance00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
American Century00 00--
Invesco00 00--
Charles Schwab00 00--
IMPAX ASSET MANAGEMENT LLC00 00--
Nuveen00 00--
BALYASNY ASSET MANAGEMENT L.P.00 00--
J. Goldman & Co LP00 00--
DE Shaw00 00--
Wellington00 00--
JACOBS LEVY EQUITY MANAGEMENT, INC00 00--
Northern Trust00 00--
PARAMETRIC PORTFOLIO ASSOCIATES LLC00 00--
Goldman Sachs00 00--
PRINCIPAL GLOBAL INVESTORS00 00--
MELLON INVESTMENTS Corp00 00--
SEI00 00--
RICE HALL JAMES & ASSOCIATES, LLC00 00--
Dimensional00 00--
Vanguard00 00--
Connor, Clark & Lunn Investment Management Ltd.00 00--

Institutional-manager reports, all 215 managers: 1,107 for, 59,771 against, 8 abstained, 16,990,957 1 year, 219,740 3 year. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 40,022,569AGAINST: 352,947
Details: description as filed, official tally, votes by 93 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

PACIRA BIOSCIENCES INC.’s own tally for this item (“2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025”): 40,022,569 for, 352,947 against, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 93 asset managers below reported 18,890,236 for, 273,711 against, 4,354 abstained.

FOR
FOR: 18,890,236AGAINST: 273,711ABSTAIN: 4,354
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCA” at PACIRA BIOSCIENCES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,391,6951 00For
BlackRock5,198,5320 00For
Fidelity1,154,1030 00For
American Century685,6990 00For
Pacer Funds Trust536,6160 00For
State Street524,42032 00For
IMPAX FUNDS SERIES TRUST I520,0270 00For
TIAA511,9810 00For
Charles Schwab470,3530 00For
Dimensional462,1290 00For
Columbia Threadneedle359,7980 00For
Invesco348,5440 00For
DWS257,1310 00For
EA Series Trust0229,057 00Against
JPMorgan201,6120 00For
Simplify Exchange Traded Funds133,3470 00For
Nationwide128,8650 00For
SEI128,1100 00For
Equitable125,1260 00For
Victory Capital115,7450 00For
Jackson National91,6850 00For
Northern Trust88,2500 00For
GuideStone79,5870 00For
QUANTITATIVE MASTER SERIES LLC78,4750 00For
AIG/SunAmerica76,4050 00For

Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).

Largest PACIRA BIOSCIENCES INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 46,283,407 shares outstanding at the time of that meeting.

Fund voting reports: top PACIRA BIOSCIENCES INC. shareholders by shares voted on “Approval, on an advisory basis, of the compensation of our named executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 11.65%
2BlackRock 11.23%
3Fidelity 2.49%
4American Century 1.48%
5Pacer Funds Trust 1.16%
6State Street 1.13%
7IMPAX FUNDS SERIES TRUST I 1.12%
8TIAA 1.11%
9Charles Schwab 1.02%
10Dimensional 1.00%
Institutional-manager reports: top PACIRA BIOSCIENCES INC. shareholders by shares voted on “Approval, on an advisory basis, of the compensation of our named executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 4.27%
2State Street 2.93%
3Alyeska Investment Group, L.P. 2.78%
4Renaissance 2.55%
5GEODE CAPITAL MANAGEMENT, LLC 2.48%
6American Century 1.59%
7Invesco 1.16%
8Charles Schwab 1.14%
9IMPAX ASSET MANAGEMENT LLC 1.12%
10Nuveen 1.12%

Reported PACIRA BIOSCIENCES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

PACIRA BIOSCIENCES INC. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock7,653,363 16.54%Form 13F, quarter ended March 31, 2025
Vanguard Group5,241,804 11.33%Form 13F, quarter ended March 31, 2025
Pacer US Small Cap Cash Cows ETF3,259,418 7.04%Schedule 13G, filed May 2, 2025
Doma Perpetual Capital Management LLC2,936,794 6.35%Schedule 13D, filed January 2, 2026
Pedro Escudero2,936,794 6.35%Schedule 13D, filed March 12, 2026
Vanguard Portfolio Management2,585,964 5.59%Schedule 13G, filed May 1, 2026
D.E. Shaw2,263,909 4.89%Form 13F, quarter ended March 31, 2025
Renaissance Technologies2,240,601 4.84%Form 13F, quarter ended March 31, 2025
Dimensional Fund Advisors2,049,431 4.43%Form 13F, quarter ended March 31, 2025
State Street1,979,361 4.28%Form 13F, quarter ended March 31, 2025

Percentages above are of 46,283,407 shares outstanding, as reported by PACIRA BIOSCIENCES INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At PACIRA BIOSCIENCES INC.'s shareholder meeting held June 10, 2025, in the 2024-2025 proxy season, 291 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 2,664 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of our named executive officers. — FOR was 40% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is not more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: PACIRA BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PACIRA BIOSCIENCES INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

PACIRA BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “PACIRA BIOSCIENCES (PCRX) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/pacira-biosciences-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.